当前位置: X-MOL 学术J. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial
Journal of Clinical Oncology ( IF 45.3 ) Pub Date : 2023 , DOI: 10.1200/jco.23.00101
Yiwen Ling 1, 2, 3 , Li Xuan 1, 2 , Na Xu 1, 2 , Fen Huang 1, 2 , Zhiping Fan 1, 2 , Ziwen Guo 4 , Xiaojun Xu 5 , Hui Liu 1, 2 , Ren Lin 1, 2 , Sijian Yu 1, 2 , Haiyan Zhang 1, 2 , Hua Jin 1, 2 , Meiqing Wu 6 , Can Liu 7 , Xinquan Liang 8 , Ruiming Ou 9 , Yuping Zhang 10 , Xiaodan Liu 11 , Hong Qu 12 , Xiao Zhai 13 , Jing Sun 1, 2 , Ying Zhao 3 , Qifa Liu 1, 2
Affiliation  

Journal of Clinical Oncology, Ahead of Print.


中文翻译:

白消安加氟达拉滨与白消安加环磷酰胺治疗接受 HLA 单倍相合造血细胞移植的 AML 的比较:多中心随机 III 期试验

临床肿瘤学杂志,印刷前。
更新日期:2023-06-20
down
wechat
bug